Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sensory-Evoked Cortical Gamma Oscillation
Sponsor: University of Tennessee Medical Center
Summary
The purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-invasive visual and auditory stimulation with pre-established markers of cortical network activity, i.e., electroencephalography (EEG) and event-related potentials (ERP), to evaluate the applicability of the 40-Hz multimodel sensory stimulation as a novel therapeutic approach for treatment of AD patients.
Official title: Sensory-Evoked Cortical Gamma Oscillation: Impact on Visual Processing and Cognitive Function in Patients With Alzheimer's Disease
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2022-07-01
Completion Date
2026-06-30
Last Updated
2024-12-06
Healthy Volunteers
No
Conditions
Interventions
GammaSense Stimulation device
Cognito Therapeutics GammaSense Stimulation device delivers sensory (auditory and visual) stimuli at a rate of 40 Hz to the wearer for one hour each day.
Locations (1)
University of Tennessee Medical Center
Knoxville, Tennessee, United States